Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: No significant correlations with clinicopathological variables and treatment outcomes

International Journal of Pediatric Otorhinolaryngology

Volumn 71, Issue 3, 2007, Pages 447-455

  Fang, Fu Min ^a   Li, Chien Feng ^b   Chien, Chih Yen ^a   Rau, Kwen Ming ^a   Huang, Hsuan Ying ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Children; COX 2; EGFR; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TAIWAN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 33846294024     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2006.11.019     Document Type: Article

References (26)

1. Chan J., Plich B.Z., Kuo T.T., et al. Nasopahryngeal carcinoma. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). WHO Health Organization Classification of Tumors-Pathology & Genetics: Head and Neck Tumors (2005), IARC Press, Lyon, France 85-97
2. Ayan I., Kaytan E., and Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol. 4 1 (2003) 13-21
3. Cammoun M., Hoerner V., and Mourali N. Tumors of the nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases. Cancer 33 1 (1974) 184-192
4. Rodriguez-Galindo C., Wofford M., Castleberry R.P., et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 103 4 (2005) 850-857
5. Ingersoll L., Woo S.Y., Donaldson S., et al. Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience. Int. J. Radiat. Oncol. Biol. Phys. 19 4 (1990) 881-887
6. Dannenberg A.J., Lippman S.M., Mann J.R., et al. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J. Clin. Oncol. 23 2 (2005) 254-266
7. Brown J.R., and DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol. 23 12 (2005) 2840-2855
8. Soo R., Putti T., Tao Q., et al. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Arch. Otolaryngol. Head Neck Surg. 131 2 (2005) 147-152
9. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 62 24 (2002) 7350-7356
10. Chen W.C., McBride W.H., Chen S.M., et al. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Head Neck 27 6 (2005) 503-512
11. Chua D.T., Nicholls J.M., Sham J.S., et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59 1 (2004) 11-20
12. Putti T.C., To K.F., Hsu H.C., et al. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 41 2 (2002) 144-151
13. Fang F.M., Tsai W.L., Go S.F., et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 50 4 (2001) 961-969
14. Yeh S.A., Tang Y., Lui C.C., et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int. J. Radiat Oncol. Biol. Phys. 62 3 (2005) 672-679
15. Sham J.S.T., Poon Y.F., Wei W.I., et al. Nasopharyngeal carcinoma in young patients. Cancer 65 (1990) 2606-2610
16. Fang F.M., Chiu H.C., Kuo W.R., et al. Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int. J. Radiat Oncol. Biol. Phys. 53 (2002) 959-968
17. F.M. Fang, W.L. Tsai, H.C. Chen, et al., Intensity-modulated or conformal radiotherapy improves quality of life of patients with nasopharyngeal carcinoma-comparisons of four radiotherapy techniques, Cancer (in press).
18. Mertens R., Granzen B., Lassay L., et al. Treatment of nasopharyngeal carcinoma in Children and Adolescence: Definitive results of a multicenter study (NPC-91-GPOG). Cancer 104 (2005) 1083-1089
19. Langendijk J.A., Leemans C.R., Buter J., et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J. Clin. Oncol. 22 (2004) 4604-4612
20. Ozyar E., Selek U., Laskar S., et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a rare cancer network study. Radiother. Oncol. 81 (2006) 39-46
21. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int. J. Radiat Oncol. Biol. Phys. 36 2 (1996) 291-304
22. Wolden S.L., Steinherz P.G., Kraus D.H., et al. Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int. J. Radiat Oncol. Biol. Phys. 46 4 (2000) 859-864
23. Laskar S., Sanghavi V., Muckaden M.A., et al. Nasopharyngeal carcinoma in children: ten years' experience at the Tata Memorial Hospital, Mumbai. Int. J. Radiat Oncol. Biol. Phys. 58 1 (2004) 189-195
24. Tan K.B., and Putti T.C. Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications. J. Clin. Pathol. 58 5 (2005) 535-538
25. Ma B.B., Poon T.C., To K.F., et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma-a prospective study. Head Neck 25 10 (2003) 864-872
26. Leong J.L., Loh K.S., Putti T.C., et al. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx. Laryngoscope 114 1 (2004) 153-157